{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:43:31Z","timestamp":1792190611328,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202211376"],"award-info":[{"award-number":["tsqn202211376"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172616"],"award-info":[{"award-number":["82172616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH097"],"award-info":[{"award-number":["ZR2021MH097"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-2019genecast-020"],"award-info":[{"award-number":["Y-2019genecast-020"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12022-025-09850-7","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:32:01Z","timestamp":1740097921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of Oncogenic Alterations in 124 Cases of Pediatric Papillary Thyroid Carcinoma: BEND7::ALK, DLG5::RET, and CCDC30::ROS1 Fusions Induce MAPK Pathway Activation"],"prefix":"10.1007","volume":"36","author":[{"given":"Yixuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longnv","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"9850_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1089\/thy.2014.0460","volume":"25","author":"GL Francis","year":"2015","unstructured":"Francis GL, Waguespack SG, Bauer AJ, et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015; 25; 716-759.","journal-title":"Thyroid"},{"key":"9850_CR2","first-page":"11","volume":"2022","author":"CA Lebbink","year":"2022","unstructured":"Lebbink CA, Links TP, Czarniecka A, et al. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J 2022; 11.","journal-title":"Eur Thyroid J"},{"key":"9850_CR3","doi-asserted-by":"publisher","first-page":"833775","DOI":"10.3389\/fonc.2022.833775","volume":"12","author":"Y Gui","year":"2022","unstructured":"Gui Y, Huang D, Hou Y, et al. Predictive Factors for Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents. Front Oncol 2022; 12; 833775.","journal-title":"Front Oncol"},{"key":"9850_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/genes10090723","volume":"10","author":"VA Paulson","year":"2019","unstructured":"Paulson VA, Rudzinski ER, Hawkins DS. Thyroid Cancer in the Pediatric Population. Genes (Basel) 2019; 10; 723.","journal-title":"Genes (Basel)"},{"key":"9850_CR5","doi-asserted-by":"publisher","first-page":"e144847","DOI":"10.1172\/JCI144847","volume":"131","author":"YA Lee","year":"2021","unstructured":"Lee YA, Lee H, Im SW, et al. NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake. J Clin Invest 2021; 131; e144847.","journal-title":"J Clin Invest"},{"key":"9850_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00383-015-3855-0","volume":"32","author":"S Golpanian","year":"2016","unstructured":"Golpanian S, Perez EA, Tashiro J, et al. Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients. Pediatr Surg Int 2016; 32; 201-208.","journal-title":"Pediatr Surg Int"},{"key":"9850_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1530\/ERC-20-0464","volume":"28","author":"A Stenman","year":"2021","unstructured":"Stenman A, Backman S, Johansson K, et al. Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma. Endocr Relat Cancer 2021; 28; 337-351.","journal-title":"Endocr Relat Cancer"},{"key":"9850_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1200\/JCO.21.01861","volume":"40","author":"AT Franco","year":"2022","unstructured":"Franco AT, Ricarte-Filho JC, Isaza A, et al. Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric Thyroid Cancers. J Clin Oncol 2022; 40; 1081-1090.","journal-title":"J Clin Oncol"},{"key":"9850_CR9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014; 159; 676-690.","journal-title":"Cell"},{"key":"9850_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/path.5005","volume":"244","author":"J Liang","year":"2018","unstructured":"Liang J, Cai W, Feng D, et al. Genetic landscape of papillary thyroid carcinoma in the Chinese population. J Pathol 2018; 244; 215-226.","journal-title":"J Pathol"},{"key":"9850_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s12022-022-09736-y","volume":"33","author":"S Onder","year":"2022","unstructured":"Onder S, Mete O, Yilmaz I, et al. DICER1 Mutations Occur in More Than One-Third of Follicular-Patterned Pediatric Papillary Thyroid Carcinomas and Correlate with a Low-Risk Disease and Female Gender Predilection. Endocr Pathol 2022; 33; 437-445.","journal-title":"Endocr Pathol"},{"key":"9850_CR12","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1158\/1538-7445.AM2024-7408","volume":"84","author":"H Tang","year":"2024","unstructured":"Tang H, Bao H, Liu R, et al. Robust profiling of cancer-related gene fusions: Analytical validation of PANCARNA for multiple cancer types. Cancer Res 2024; 84; 7408-7408.","journal-title":"Cancer Res"},{"key":"9850_CR13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21536","volume":"6","author":"I Gudernova","year":"2017","unstructured":"Gudernova I, Foldynova-Trantirkova S, Ghannamova BE, et al. One reporter for in-cell activity profiling of majority of protein kinase oncogenes. Elife 2017; 6; e21536.","journal-title":"Elife"},{"key":"9850_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1089\/thy.2016.0673","volume":"27","author":"K Iyama","year":"2017","unstructured":"Iyama K, Matsuse M, Mitsutake N, et al. Identification of Three Novel Fusion Oncogenes, SQSTM1\/NTRK3, AFAP1L2\/RET, and PPFIBP2\/RET, in Thyroid Cancers of Young Patients in Fukushima. Thyroid 2017; 27; 811-818.","journal-title":"Thyroid"},{"key":"9850_CR15","doi-asserted-by":"publisher","first-page":"e230117","DOI":"10.1530\/ERC-23-0117","volume":"30","author":"B Bulanova Pekova","year":"2023","unstructured":"Bulanova Pekova B, Sykorova V, Mastnikova K, et al. RET fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis. Endocr Relat Cancer 2023; 30; e230117.","journal-title":"Endocr Relat Cancer"},{"key":"9850_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<97::AID-GCC4>3.0.CO;2-L","volume":"25","author":"T Nakata","year":"1999","unstructured":"Nakata T, Kitamura Y, Shimizu K, et al. Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma. Genes Chromosomes Cancer 1999; 25; 97-103.","journal-title":"Genes Chromosomes Cancer"},{"key":"9850_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/gcc.10095","volume":"35","author":"T Nakata","year":"2002","unstructured":"Nakata T, Yokota T, Emi M, Minami S. Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma. Genes Chromosomes Cancer 2002; 35; 30-37.","journal-title":"Genes Chromosomes Cancer"},{"key":"9850_CR18","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1038\/s41379-020-0638-5","volume":"33","author":"YH Chu","year":"2020","unstructured":"Chu YH, Wirth LJ, Farahani AA, et al. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization. Mod Pathol 2020; 33; 2458-2472.","journal-title":"Mod Pathol"},{"key":"9850_CR19","doi-asserted-by":"publisher","first-page":"13913","DOI":"10.1038\/s41598-022-17791-y","volume":"12","author":"L Zhou","year":"2022","unstructured":"Zhou L, Li J, Zhang X, et al. An integrative pan cancer analysis of RET aberrations and their potential clinical implications. Sci Rep 2022; 12; 13913.","journal-title":"Sci Rep"},{"key":"9850_CR20","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.21037\/gs-23-252","volume":"12","author":"S Toda","year":"2023","unstructured":"Toda S, Yamamoto Y, Ookubo Y, et al. Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case report. Gland Surg 2023; 12; 1441-1448.","journal-title":"Gland Surg"},{"key":"9850_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1210\/clinem\/dgad500","volume":"109","author":"G Ju","year":"2023","unstructured":"Ju G, Sun Y, Wang H, et al. Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer. J Clin Endocrinol Metab 2023; 109; 505-515.","journal-title":"J Clin Endocrinol Metab"},{"key":"9850_CR22","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1158\/1078-0432.CCR-17-1183","volume":"23","author":"T Ibrahimpasic","year":"2017","unstructured":"Ibrahimpasic T, Xu B, Landa I, et al. Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clin Cancer Res 2017; 23; 5970-5980.","journal-title":"Clin Cancer Res"},{"key":"9850_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.21053\/ceo.2021.02215","volume":"15","author":"SJ Park","year":"2022","unstructured":"Park SJ, Kang YE, Kim JH, et al. Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and Recurrence. Clin Exp Otorhinolaryngol 2022; 15; 183-193.","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"9850_CR24","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1210\/clinem\/dgad220","volume":"108","author":"S Chiosea","year":"2023","unstructured":"Chiosea S, Hodak SP, Yip L, et al. Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management. J Clin Endocrinol Metab 2023; 108; 2999-3008.","journal-title":"J Clin Endocrinol Metab"},{"key":"9850_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jmoldx.2023.04.007","volume":"25","author":"S Wu","year":"2023","unstructured":"Wu S, Liu Y, Li K, Liang Z, Zeng X. Molecular and Cytogenetic Features of NTRK Fusions Enriched in BRAF and RET Double-Negative Papillary Thyroid Cancer. J Mol Diagn 2023; 25; 569-582.","journal-title":"J Mol Diagn"},{"key":"9850_CR26","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1038\/ncomms5846","volume":"5","author":"N Stransky","year":"2014","unstructured":"Stransky N, Cerami E, Schalm S, Kim JL, Lengauer C. The landscape of kinase fusions in cancer. Nat Commun 2014; 5; 4846.","journal-title":"Nat Commun"},{"key":"9850_CR27","first-page":"255","volume":"22","author":"P Vanden Borre","year":"2017","unstructured":"Vanden Borre P, Schrock AB, Anderson PM, et al. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions. Oncologist 2017; 22; 255-263.","journal-title":"Including Kinase Fusions. Oncologist"},{"key":"9850_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3892\/mco.2021.2373","volume":"15","author":"AK Murugan","year":"2021","unstructured":"Murugan AK, Qasem E, Al\u2011Hindi H, Alzahrani AS. Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers. Mol Clin Oncol 2021; 15; 210.","journal-title":"Mol Clin Oncol"},{"key":"9850_CR29","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1089\/thy.2016.0101","volume":"26","author":"LL Ritterhouse","year":"2016","unstructured":"Ritterhouse LL, Wirth LJ, Randolph GW, et al. ROS1 Rearrangement in Thyroid Cancer. Thyroid 2016; 26; 794-797.","journal-title":"Thyroid"},{"key":"9850_CR30","doi-asserted-by":"publisher","first-page":"11560","DOI":"10.1200\/JCO.2016.34.15_suppl.11560","volume":"34","author":"L Ritterhouse","year":"2016","unstructured":"Ritterhouse L, Dias-Santagata D, Nardi V, et al. The landscape of clinically actionable ALK\/MET\/RET\/ROS1 fusions to reveal a shared pattern of protein domains in fusion partners. J Clin Oncol 2016; 34; 11560.","journal-title":"J Clin Oncol"},{"key":"9850_CR31","first-page":"PO.17.00105","volume":"1","author":"SV Liu","year":"2017","unstructured":"Liu SV, Macke LA, Colton BS, et al. Response to Entrectinib in Differentiated Thyroid Cancer With a ROS1 Fusion. JCO Precis Oncol 2017; 1; PO.17.00105.","journal-title":"JCO Precis Oncol"},{"key":"9850_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/thy.2021.0217","volume":"32","author":"JR Hess","year":"2022","unstructured":"Hess JR, Newbern DK, Beebe KL, Walsh AM, Schafernak KT. High Prevalence of Gene Fusions and Copy Number Alterations in Pediatric Radiation Therapy-Induced Papillary and Follicular Thyroid Carcinomas. Thyroid 2022; 32; 411-420.","journal-title":"Thyroid"},{"key":"9850_CR33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2018.01.021","volume":"33","author":"PK-S Ng","year":"2018","unstructured":"Ng PK-S, Li J, Jeong KJ, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell 2018; 33; 450-462.e410.","journal-title":"Cancer Cell"},{"key":"9850_CR34","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1089\/thy.2019.0802","volume":"30","author":"B Pekova","year":"2020","unstructured":"Pekova B, Sykorova V, Dvorakova S, et al. RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas. Thyroid 2020; 30; 1771-1780.","journal-title":"Thyroid"},{"key":"9850_CR35","doi-asserted-by":"publisher","first-page":"5625","DOI":"10.1158\/0008-5472.CAN-21-0761","volume":"81","author":"A Stosic","year":"2021","unstructured":"Stosic A, Fuligni F, Anderson ND, et al. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma. Cancer Res 2021; 81; 5625-5637.","journal-title":"Cancer Res"},{"key":"9850_CR36","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1210\/clinem\/dgaa389","volume":"105","author":"AS Alzahrani","year":"2020","unstructured":"Alzahrani AS, Alswailem M, Alswailem AA, et al. Genetic Alterations in Pediatric Thyroid Cancer Using a Comprehensive Childhood Cancer Gene Panel. J Clin Endocrinol Metab 2020; 105.","journal-title":"J Clin Endocrinol Metab"},{"key":"9850_CR37","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/cncr.29887","volume":"122","author":"ML Prasad","year":"2016","unstructured":"Prasad ML, Vyas M, Horne MJ, et al. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States. Cancer 2016; 122; 1097-1107.","journal-title":"Cancer"},{"key":"9850_CR38","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.21037\/gs-20-430","volume":"9","author":"FA Rashid","year":"2020","unstructured":"Rashid FA, Munkhdelger J, Fukuoka J, Bychkov A. Prevalence of BRAF(V600E) mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic review. Gland Surg 2020; 9; 1878-1900.","journal-title":"Gland Surg"},{"key":"9850_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/his.12902","volume":"69","author":"JY Joung","year":"2016","unstructured":"Joung JY, Kim TH, Jeong DJ, et al. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications. Histopathology 2016; 69; 45-53.","journal-title":"Histopathology"},{"key":"9850_CR40","doi-asserted-by":"publisher","first-page":"100329","DOI":"10.1016\/j.modpat.2023.100329","volume":"36","author":"A Chou","year":"2023","unstructured":"Chou A, Qiu MR, Crayton H, et al. A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma. Mod Pathol 2023; 36; 100329.","journal-title":"Mod Pathol"},{"key":"9850_CR41","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00428-024-03777-w","volume":"485","author":"Y Okubo","year":"2024","unstructured":"Okubo Y, Toda S, Kadoya M, et al. Clinicopathological analysis of thyroid carcinomas with the RET and NTRK fusion genes: characterization for genetic analysis. Virchows Arch 2024; 485; 509-518.","journal-title":"Virchows Arch"},{"key":"9850_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.humpath.2024.06.004","volume":"149","author":"I Tondi Resta","year":"2024","unstructured":"Tondi Resta I, Rind A, Montone KT, Livolsi VA, Baloch ZW. A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions. Hum Pathol 2024; 149; 29-38.","journal-title":"Hum Pathol"},{"key":"9850_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12022-024-09808-1","volume":"35","author":"KP Shih","year":"2024","unstructured":"Shih KP, Lee YC, Tsai JJ, et al. Clinicopathologic Features and Cytologic Correlation of ALK-Rearranged Papillary Thyroid Carcinoma: A Series of Eight Cases. Endocr Pathol 2024; 35; 134-146.","journal-title":"Endocr Pathol"},{"key":"9850_CR44","doi-asserted-by":"publisher","first-page":"i71","DOI":"10.1093\/jrr\/rraa096","volume":"62","author":"N Mitsutake","year":"2021","unstructured":"Mitsutake N, Saenko V. Molecular pathogenesis of pediatric thyroid carcinoma. J Radiat Res 2021; 62; i71-i77.","journal-title":"J Radiat Res"},{"key":"9850_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1210\/clinem\/dgad458","volume":"109","author":"H Li","year":"2023","unstructured":"Li H, Han R, Meng L, et al. Nodal Metastases Associated with Fusion Oncogenes Are Age Dependent in Young Adult Patients with Thyroid Cancer. J Clin Endocrinol Metab 2023; 109; 143-150.","journal-title":"J Clin Endocrinol Metab"},{"key":"9850_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12022-024-09836-x","volume":"35","author":"O Mete","year":"2024","unstructured":"Mete O, Boucher A, Schrader KA, et al. Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management. Endocr Pathol 2024; 35; 293-308.","journal-title":"Endocr Pathol"},{"key":"9850_CR47","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1210\/jc.2017-02698","volume":"103","author":"JD Wasserman","year":"2018","unstructured":"Wasserman JD, Sabbaghian N, Fahiminiya S, et al. DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 2018; 103; 2009-2015.","journal-title":"J Clin Endocrinol Metab"},{"key":"9850_CR48","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s12022-021-09688-9","volume":"32","author":"JS Bae","year":"2021","unstructured":"Bae JS, Jung SH, Hirokawa M, et al. High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid. Endocr Pathol 2021; 32; 336-346.","journal-title":"Endocr Pathol"},{"key":"9850_CR49","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1089\/thy.2024.0188","volume":"34","author":"K Mastnikova","year":"2024","unstructured":"Mastnikova K, Bulanova Pekova B, Kuklikova V, et al. DICER1 Variants in Pediatric and Young Adult Thyroid Nodules. Thyroid 2024; 34; 1225-1233.","journal-title":"Thyroid"},{"key":"9850_CR50","doi-asserted-by":"publisher","first-page":"1267499","DOI":"10.3389\/fendo.2023.1267499","volume":"14","author":"E Minna","year":"2023","unstructured":"Minna E, Devecchi A, Pistore F, et al. Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors. Front Endocrinol (Lausanne) 2023; 14; 1267499.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9850_CR51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00428-021-03212-4","volume":"480","author":"CA Ghossein","year":"2022","unstructured":"Ghossein CA, Dogan S, Farhat N, Landa I, Xu B. Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform. Virchows Arch 2022; 480; 293-302.","journal-title":"Virchows Arch"},{"key":"9850_CR52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12022-023-09780-2","volume":"34","author":"G Yegen","year":"2023","unstructured":"Yegen G, Altay AY, Y\u0131lmaz \u0130, et al. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas. Endocr Pathol 2023; 34; 279-286.","journal-title":"Endocr Pathol"},{"key":"9850_CR53","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/PAS.0000000000002265","volume":"48","author":"J Ver Berne","year":"2024","unstructured":"Ver Berne J, Van den Bruel A, Vermeire S, De Paepe P. DICER1 Mutations Define the Landscape of Poorly Differentiated Thyroid Carcinoma in Children and Young Adults: Case Report and Literature Review. Am J Surg Pathol 2024; 48; 1277-1283.","journal-title":"Am J Surg Pathol"},{"key":"9850_CR54","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12022-024-09842-z","volume":"35","author":"RD Whaley","year":"2024","unstructured":"Whaley RD, Gupta S, Manninen MC, O'Brien DR, Erickson LA. Clinicopathologic and Molecular Analysis of 15 Pediatric and Young Adult Patients with High-Grade Non-anaplastic Thyroid Carcinoma. Endocr Pathol 2024; 35; 397-410.","journal-title":"Endocr Pathol"},{"key":"9850_CR55","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1101\/gad.213314.113","volume":"27","author":"Q Dai","year":"2013","unstructured":"Dai Q, Ren A, Westholm JO, et al. The BEN domain is a novel sequence-specific DNA-binding domain conserved in neural transcriptional repressors. Genes Dev 2013; 27; 602-614.","journal-title":"Genes Dev"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-025-09850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-025-09850-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-025-09850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:01:40Z","timestamp":1768248100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-025-09850-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9850"],"URL":"https:\/\/doi.org\/10.1007\/s12022-025-09850-7","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"11 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5"}}